Literature DB >> 2298418

Prognostic significance of flow cytometry studies in B-cell non-Hodgkin lymphoma.

S Rehn1, B Glimelius, P Strang, C Sundström, B Tribukait.   

Abstract

The prognostic relevance of flow cytometric DNA measurements of lymph node biopsies in relation to histopathology according to the Kiel classification, stage, age and presence or absence of B-symptoms was investigated in 106 patients with non-Hodgkin lymphomas (NHL) of proven B-cell type. Biopsies were taken at diagnosis before treatment. The mean proportion of cells in S-phase was significantly lower in the 76 patients with a 'low grade' NHL (4.4 per cent) than in the 30 patients with a 'high grade' NHL (13.0 per cent) (p less than 0.0001). High S-phase rates were associated with a poor prognosis within the whole material (p less than 0.01) and within the group of 'high grade' NHL (p less than 0.05). In the subgroup CB-CC lymphomas of 'low grade' NHL, the prognostic value of the S-phase rate was stronger than any other investigated parameter (p less than 0.05). In multivariate analyses, the S-phase rate gave, in several subgroups, independent prognostic information, besides clinico-pathological variables.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2298418     DOI: 10.1002/hon.2900080102

Source DB:  PubMed          Journal:  Hematol Oncol        ISSN: 0278-0232            Impact factor:   5.271


  8 in total

1.  DNA flow cytometry of follicular non-Hodgkin's lymphoma.

Authors:  J C Macartney; R S Camplejohn; R Morris; K Hollowood; D Clarke; A Timothy
Journal:  J Clin Pathol       Date:  1991-03       Impact factor: 3.411

2.  Nucleolar organiser regions and survival in patients with non-Hodgkin's lymphomas classified by the working formulation.

Authors:  J Jakić-Razumović; D Tentor; M Petrovecki; I Radman
Journal:  J Clin Pathol       Date:  1993-10       Impact factor: 3.411

3.  Tumour cell proliferation, but not apoptosis, predicts survival in B-cell non-Hodgkin's lymphomas.

Authors:  T Stokke; E B Smeland; S Kvaløy; H Holte
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

4.  Lymphocyte homing receptor (CD44) expression is associated with poor prognosis in gastrointestinal lymphoma.

Authors:  H Joensuu; R Ristamäki; P J Klemi; S Jalkanen
Journal:  Br J Cancer       Date:  1993-08       Impact factor: 7.640

5.  Contribution of 3H-thymidine labelling index and flow cytometric S-phase in predicting survival of patients with non-Hodgkin's lymphoma.

Authors:  A Costa; R Silvestrini; R Giardini; G Messina-Gabrielli; P Boracchi; S Veneroni
Journal:  Br J Cancer       Date:  1992-10       Impact factor: 7.640

6.  Proliferation and apoptosis in malignant and normal cells in B-cell non-Hodgkin's lymphomas.

Authors:  T Stokke; H Holte; L Smedshammer; E B Smeland; O Kaalhus; H B Steen
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

7.  Deoxythymidine kinase in the tumour cells and serum of patients with non-Hodgkin lymphomas.

Authors:  S Rehn; J S Gronowitz; C Källander; C Sundström; B Glimelius
Journal:  Br J Cancer       Date:  1995-05       Impact factor: 7.640

8.  Expression levels of TWIST1 are associated with the clinicopathological stage of B-cell non-Hodgkin lymphoma.

Authors:  Cundong Jia; Liping Liang; Lili Yang; Feng Zhao; Jingping Bai
Journal:  Exp Ther Med       Date:  2014-09-15       Impact factor: 2.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.